v3.26.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
A. Cash flows from operating activities    
Net loss $ (14,621,113) $ (25,622,303)
Adjustments to reconcile net loss to net cash used in operating activities :    
Depreciation and amortization 91,766 433,906
Interest on redeemable promissory note 1,995,967
Amortisation of discount and debt issuance cost on redeemable promissory notes 1,765,615
Interest on unsecured loans 229,582
Interest on Convertible notes 56,849
Interest on finance leases 279,710 550,903
Loss on modification of finance leases 456,714
Change in fair value of Unsecured Convertible Note 539,805 (1,740,636)
Change in fair value of derivative financial instruments (9,035,085)
Issuance cost towards issue of warrants 3,294,526
Gain on sale and disposal of assets, net 2,188 (114)
Gain on sale and disposal of assets held for sale, net (10,755) (1,054)
Gain on derecognition of subsidiary, net [1] (1,748,507)
Stock based compensation 1,453,968 52,461
Assets written off 110,720 853,194
Liabilities written off (1,272,825) (219,284)
Payable to customers and provision written back (102,815) (227,643)
Gain on recovery of goods and service tax receivable (439,204)
Interest on subcontractor liability   91,891
Liquidated damages 2,568,936 570,893
Bad debts against receivables from car sale 452,014
Loss on extinguishment of liability [2] 3,458,248
Gain on troubled debt restructuring (72,912) (1,171,161)
Impairment on assets held for sale 23,789 448,484
Host receivable written off 54,955 202,944
Loss on litigation settlement 5,300,395 12,738,865
Loss on settlement 42,558
Unrealized foreign currency exchange loss, net 15,169 2,137
Loss on withdrawal of lease waiver 1,131,835
Adjustments to reconcile net loss to net cash used in operating activities (6,365,906) (10,648,518)
Changes in operating assets and liabilities :    
Decrease/(Increase) in accounts receivable 87,101 (13,668)
Decrease in balances with government authorities 620,522 200,769
Decrease in prepaid expenses 350,283 481,521
(Increase) in other assets (65,058) (230,295)
Increase in accounts payables 3,498,750 1,551,898
Increase in other liabilities 410,724 615,550
Increase/(Decrease) in pension and other employee obligations 9,567 (267,854)
Decrease in operating lease right of use asset 198,490 239,335
(Decrease) in operating lease liabilities (198,429) (224,868)
Increase/(Decrease) in contract liabilities 94,656 (229,034)
Net cash used in operating activities (A) (1,359,300) (8,525,164)
B. Cash flows from investing activities    
Payment for purchase of property and equipment, including intangible assets (4,748) (12,012)
Proceeds from sale of asset held for sale 17,333 144,538
(Investments in) / proceeds from fixed deposits (1,545) 359,614
Net cash generated from investing activities (B) 11,040 492,140
C. Cash flows from financing activities    
Proceeds from issue of equity and warrants (including prepayment of exercise price on pre funded warrants) 16,073,284
Payment of issuance cost towards issue of common stock and warrants (2,370,799)
Proceeds from issue of redeemable promissory notes 3,000,000
Payment of redeemable promissory note issue expenses (491,500)
Repayment of redeemable promissory note (3,804,000)
Proceeds from Unsecured notes 1,275,000
Payment of Unsecured notes issuance cost (97,000)
Repayment of Unsecured notes (596,401)
Proceeds from Convertible notes 409,500
Payment of Convertible notes issuance cost (15,000)
Proceeds from issue of debt 595,520 1,069,500
Principal repayment of debt (674,038) (3,104,032)
Principal payment of finance lease obligation (289,228) (2,654,122)
Net cash generated from financing activities (C) 608,353 7,718,331
Net decrease in cash and cash equivalents and restricted cash (A+B+C) (739,907) (314,693)
Effect of foreign exchange on cash and cash equivalents. (103,008) (9,414)
Cash and cash equivalents and restricted cash    
Cash and cash equivalents at the beginning of period 1,077,275 1,496,144
Restricted cash included under other non-current assets at the beginning of period 94,762
Cash and cash equivalents derecognized due to derecognition of subsidiary (536)
End of period 328,586 1,172,037
Reconciliation of cash, cash equivalents and restricted cash to the Consolidated Balance Sheets    
Cash and cash equivalents 328,586 1,077,275
Restricted cash and cash equivalents included under other non-current assets 94,762
Total cash and cash equivalents and restricted cash shown in Consolidated Statement of Cash Flows 328,586 1,172,037
Supplemental disclosures of cash flow information    
Cash paid for income taxes (4,052)
Interest paid on debt (190,802) (307,354)
Supplemental disclosures of non-cash investing and financing activities:    
Issue of Common stock upon conversion of unsecured convertible Note 2,324,696
Issue of Common Stock and warrants 16,158,811
Reclassification of warrants from liability to equity 8,366,650
Issue of Common Stock upon cashless exercise of warrants 92,791
Issue of warrants to redeemable promissory note holders 2,047,925
Issue of common stock upon exercise of warrants issued with redeemable promissory notes 5
Conversion of unsecured promissory note into equity (shares pending issuance) 2,027,840
Warrants issued to placement agents towards issue of redeemable promissory notes 418,157
Warrants issued to placement agents 1,540,167
Acquisition of assets held for sale by incurring a liability 238,689
Issue of common stock upon exercise of warrants 634
Issue of prefunded warrants in exchange of common stock 240
Issue of prefunded warrants in lieu of liquidated damages payable 2,931,457
Warrants pending issuance in lieu of placement agent fees $ 14,139
[1] This is a gain of $1,748,507 net of Company’s cost of investment and related liabilities of the subsidiaries resulting from the derecognition of Zoomcar Vietnam Mobility LLC, Egypt Information Technology Platform LLC, and Zoomcar Netherlands Holding B. V.
[2] On March 31, 2025, the Company entered into settlement agreement with certain investors in exchange for waivers of rights under prior financing agreements. Pursuant to the Settlement Agreement, the Company agreed to issue shares and warrants to them.